Technology
Health
Pharmaceutical

Aclaris Therapeutics

$2.21
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-0.90%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ACRS and other stocks, options, ETFs, and crypto commission-free!

About ACRS

CEO
Employees
169
Headquarters
Founded
2012
Market Cap
92.03M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
531.09K
High Today
$2.25
Low Today
$2.17
Open Price
$2.21
Volume
157.71K
52 Week High
$20.80
52 Week Low
$1.93

Collections

Technology
Health
Pharmaceutical
Therapy
Medical
Biopharmaceutical
2015 IPO
US

ACRS News

BenzingaJul 9

Aclaris Shares Trade Higher On Patent Win For Facial Redness Drug

99
BenzingaJun 27

What Caused The Opening Gap In Aclaris Therapeutics?

499
Yahoo FinanceJun 14

Aclaris Therapeutics to Present at the 2019 JMP Securities Life Sciences Conference

135

ACRS Earnings

-$1.33
-$1.15
-$0.98
-$0.80
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 2, After Hours

More ACRS News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.